首页> 外国专利> ACTIVATING TRANSCRIPTION FACTOR 3 WHICH IS USED AS A NOVEL THERAPEUTIC TARGET AND FOR PREDICTING TOXICITY

ACTIVATING TRANSCRIPTION FACTOR 3 WHICH IS USED AS A NOVEL THERAPEUTIC TARGET AND FOR PREDICTING TOXICITY

机译:激活转录因子3,用作新的治疗靶标并用于预测毒性

摘要

PURPOSE: Activating transcription factor 3 (ATF3) is provided to show enhanced activity by a chemotherapeutic agent for anticancer, thereby being used as a marker for predicting toxicity in organs.;CONSTITUTION: A method for predicting cytotoxicity comprises the steps of measuring the gene expression level or protein level of ATF3 in a biological sample; and comparing the gene expression level or protein level of ATF3 in the biological sample with the gene expression level or protein level of ATF3 in a control group. A composition reducing cytotoxicity contains an ATF3 expression inhibitor.;COPYRIGHT KIPO 2013
机译:目的:提供激活转录因子3(ATF3)以显示化学治疗剂增强的抗癌活性,从而用作预测器官毒性的标志物。;组成:预测细胞毒性的方法包括测量基因表达的步骤生物样品中ATF3的水平或蛋白质水平;将生物样品中ATF3的基因表达水平或蛋白质水平与对照组中ATF3的基因表达水平或蛋白质水平进行比较。降低细胞毒性的组合物包含ATF3表达抑制剂。; COPYRIGHT KIPO 2013

著录项

  • 公开/公告号KR20130101793A

    专利类型

  • 公开/公告日2013-09-16

    原文格式PDF

  • 申请/专利号KR20120022806

  • 发明设计人 CHOI SANG DUN;

    申请日2012-03-06

  • 分类号G01N33/68;C12Q1/68;C12N15/11;G01N33/53;

  • 国家 KR

  • 入库时间 2022-08-21 16:26:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号